476 related articles for article (PubMed ID: 29570862)
1. Medical and surgical management of advanced Parkinson's disease.
Antonini A; Moro E; Godeiro C; Reichmann H
Mov Disord; 2018 Jul; 33(6):900-908. PubMed ID: 29570862
[TBL] [Abstract][Full Text] [Related]
2. Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.
Antonini A; Nitu B
J Neural Transm (Vienna); 2018 Aug; 125(8):1131-1135. PubMed ID: 30006821
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review.
Cabreira V; Soares-da-Silva P; Massano J
Drugs; 2019 Apr; 79(6):593-608. PubMed ID: 30905034
[TBL] [Abstract][Full Text] [Related]
4. Current and novel infusion therapies for patients with Parkinson's disease.
Antonini A; D'Onofrio V; Guerra A
J Neural Transm (Vienna); 2023 Nov; 130(11):1349-1358. PubMed ID: 37672049
[TBL] [Abstract][Full Text] [Related]
5. [Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease].
Antonini A; Jost WH
Fortschr Neurol Psychiatr; 2018 Sep; 86(S 01):S5-S9. PubMed ID: 30107620
[TBL] [Abstract][Full Text] [Related]
6. Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine.
Fabbri M; Ferreira JJ; Lees A; Stocchi F; Poewe W; Tolosa E; Rascol O
Mov Disord; 2018 Oct; 33(10):1528-1539. PubMed ID: 30264443
[TBL] [Abstract][Full Text] [Related]
7. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.
Antonini A; Stoessl AJ; Kleinman LS; Skalicky AM; Marshall TS; Sail KR; Onuk K; Odin PLA
Curr Med Res Opin; 2018 Dec; 34(12):2063-2073. PubMed ID: 30016901
[TBL] [Abstract][Full Text] [Related]
8. New treatments for levodopa-induced motor complications.
Rascol O; Perez-Lloret S; Ferreira JJ
Mov Disord; 2015 Sep; 30(11):1451-60. PubMed ID: 26293004
[TBL] [Abstract][Full Text] [Related]
9. Treatment of levodopa-induced motor complications.
Stocchi F; Tagliati M; Olanow CW
Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681
[TBL] [Abstract][Full Text] [Related]
10. Levodopa-related wearing-off in Parkinson's disease: identification and management.
Pahwa R; Lyons KE
Curr Med Res Opin; 2009 Apr; 25(4):841-9. PubMed ID: 19228103
[TBL] [Abstract][Full Text] [Related]
11. Drugs for Parkinson's disease.
Treat Guidel Med Lett; 2013 Nov; 11(135):101-6. PubMed ID: 24165688
[TBL] [Abstract][Full Text] [Related]
12. International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease.
Fox SH; Katzenschlager R; Lim SY; Barton B; de Bie RMA; Seppi K; Coelho M; Sampaio C;
Mov Disord; 2018 Aug; 33(8):1248-1266. PubMed ID: 29570866
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinson's disease.
Clarke CE; Worth P; Grosset D; Stewart D
Parkinsonism Relat Disord; 2009 Dec; 15(10):728-41. PubMed ID: 19805000
[TBL] [Abstract][Full Text] [Related]
14. Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions.
Ramirez-Zamora A; Molho E
Expert Rev Neurother; 2014 Jan; 14(1):93-103. PubMed ID: 24328720
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology review of opicapone for the treatment of Parkinson's disease.
Fabbri M; Rosa MM; Ferreira JJ
Neurodegener Dis Manag; 2016 Oct; 6(5):349-62. PubMed ID: 27599671
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.
Wirdefeldt K; Odin P; Nyholm D
CNS Drugs; 2016 May; 30(5):381-404. PubMed ID: 27138916
[TBL] [Abstract][Full Text] [Related]
17. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
18. [Application of levodopa/carbidopa intestinal gel in advanced Parkinson's disease].
Toth A; Nagy H; Wacha J; Bereczki D; Takáts A
Neuropsychopharmacol Hung; 2015 Dec; 17(4):191-6. PubMed ID: 26727723
[TBL] [Abstract][Full Text] [Related]
19. Use of advanced therapies for Parkinson's disease in Norway.
Ezat B; Pihlstrøm L; Aasly J; Tysnes OB; Egge A; Dietrichs E
Tidsskr Nor Laegeforen; 2017 May; 137(9):619-623. PubMed ID: 28468476
[TBL] [Abstract][Full Text] [Related]
20. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
Oertel W; Schulz JB
J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
